Health Affairs1h
Towards A National Action Plan To Improve Representation In Clinical Trials
The time is now to align on a shared plan of action as a country to achieve diversity, equity, inclusion, and access in US ...
Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
Cencora, Inc. (NYSE: COR) today announced that it has entered into a definitive agreement to acquire Retina Consultants of America ("RCA"), a leading management services organization (MSO) of retina ...
PharmiWeb8h
Global Pediatric Clinical Trial Market Set for Remarkable Growth USD 31,661.0 million by 2034 as Demand for Child Health Solutions Surges | FMI
The global pediatric clinical trial market is poised for significant growth at a CAGR of 5.9% from 2024 to 2034. The global market size is projected to reach USD 17,918.1 million in 2024. By 2034, the ...
Medindia8h
New Study Compares Caldolor® (ibuprofen injection) to ketorolac
Real World Study Compared Over 150,000 Adult & Pediatric Patients ––        Caldolor Associated with Fewer Adverse Drug Reactions ––        Caldolor also Improved Healthcare Utilization – This ...
Government Executive21h
Beefing up Border Patrol is a bipartisan goal, but the agency has a troubled history of violence and impunity
These ideas may sound reasonable enough. Yet, as my research on the history of border enforcement reveals, flooding the zone ...
manilatimes23h
Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition
PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency in the United States, and for the treatment of PK deficiency in ...